Globe Scientific Introduces New Enhanced & Portable Clinical Centrifuges
By LabMedica International staff writers Posted on 03 Aug 2022 |
Globe Scientific, Inc. (Mahwah, NJ, USA) has introduced two new centrifuges to expand on its successful range of benchtop laboratory equipment. The expansion adds a new GCC-P portable clinical centrifuge as well as a new GCC-E50 which allows for spins of 50mL centrifuge tubes at an economical cost.
The GCC-P portable clinical centrifuge is designed for easy transport to facilitate convenient field separations using the included 12VDC car power adapter. It is compact in size and packed with the features required for routine clinical applications. The included six-position rotor accommodates 1.5mL to 5mL, 7mL, 10mL and 15mL tubes (all adapters are included). A weighted base ensures the unit remains stable in field environments. An easy-to-read LCD display shows both time and speed or RCF. Two program buttons enable simple programming and recall of regularly used methods. The timer will not count down until the set speed is reached to ensure your separations and experiments work as intended. Safety is maintained by an automatic lid lock that only disengages when the program is completed or manually once the unit has completely stopped.
Globe Scientific’s GCC-E50 enhanced clinical centrifuge is an economical solution for 15mL and 50mL separations with an enhanced user interface, easy to read backlit LCD display, tight accuracy, and automated self-diagnostics on startup. An extension based on the company’s GCC-E enhanced clinical centrifuge, the GCC-E50 employs a new rotor for spinning up to six 50mL centrifuge tubes or six 15mL centrifuge tubes.
Related Links:
Globe Scientific, Inc.
Latest Molecular Diagnostics News
- Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays